[Elsevier] Correspondence on ‘Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind

paik Post time Yesterday 15:21 | Show all posts |Read mode
This post will be closed automatically in 2026-09-17 15:20
Reward20points

Correspondence on ‘Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study’ by Mysler et al

journal:Annals of the Rheumatic Diseases

Authors:Wenpeng Zhang; Yiwen Ding; Xiaowei Zhang; Meng Dong

Published date:2026-9-

DOI:10.1016/j.ard.2026.04.014

PDF link:https://www.sciencedirect.com/sc ... 003496726002748/pdf

Article link:https://doi.org/10.1016/j.ard.2026.04.014

Article Source:Elsevier BV


Remark:

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Terik Post time Yesterday 15:21 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    210


Return to the list